𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression

✍ Scribed by Bilalovic, Nurija; Sandstad, Berit; Golouh, Rastko; Nesland, Jahn M; Selak, Ivan; Torlakovic, Emina E

Book ID
109888020
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
369 KB
Volume
17
Category
Article
ISSN
0893-3952

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tumor progression in human malignant mel
Tumor progression in human malignant melanoma is associated with changes in Ξ±6/Ξ²1 laminin receptor
✍ Pier Giorgio Natali; Maria Rita Nicotra; Renato Cavaliere; Diana Giannarelli; Al πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 656 KB

Cells of the melanocytic lineage have been shown to be capable of producing laminin and to lose this property during transformation. In the present study, we have evaluated im- munohistochemically whether these changes are paralleled by an altered expression of the a6@l laminin receptor. Results of

Galectin-1 expression in cancer-associat
Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer
✍ Eun-Jung Jung; Hyeong-Gon Moon; Bok Im Cho; Chi-Young Jeong; Young-Tae Joo; Youn πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 333 KB

## Abstract Understanding the molecular background of breast cancer biology is critical in developing new biomarkers for earlier diagnosis and more optimized treatment. We performed a proteomic analysis of human breast carcinoma tissues to investigate the tumor‐specific protein expression in breast

Glycoprotein P3.58, associated with tumo
Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen
✍ Bcrnhard Hulzmann; Jiirgen M. Lkhmann; H. W. LΓΆms Ziegler-Heitbrock; Ilona Funke πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 878 KB

The P3.58 antigen is defined by monoclonal antibodies (MAbs) selected to discriminate between benign and malignant melanocytic cells. Its expression in malignant cells has been shown to correlate with an increased risk of metastasis. A survey of a wide range of tissues revealed that, on normal tissu